Market Value3,370,348,920
Total Holdings73
File Date2025-11-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
GMED / Globus Medical, Inc.
TECX / Tectonic Therapeutic, Inc.
SRZN / Surrozen, Inc.
NEO / NeoGenomics, Inc.
MRVI / Maravai LifeSciences Holdings, Inc.
DRUG / Bright Minds Biosciences Inc.
THC / Tenet Healthcare Corporation
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
TMO / Thermo Fisher Scientific Inc.
ENGN / enGene Therapeutics Inc.
NVCR / NovoCure Limited
ZURA / Zura Bio Limited
TMDX / TransMedics Group, Inc.
CAI / Caris Life Sciences, Inc.
ACAD / ACADIA Pharmaceuticals Inc.
RNA / Atrium Therapeutics, Inc.
NBIX / Neurocrine Biosciences, Inc.
VKTX / Viking Therapeutics, Inc.
CVS / CVS Health Corporation
RGEN / Repligen Corporation
ARGX / argenx SE - Depositary Receipt (Common Stock)
AMLX / Amylyx Pharmaceuticals, Inc.
EHC / Encompass Health Corporation
DHR / Danaher Corporation
CGON / CG Oncology, Inc.
VERA / Vera Therapeutics, Inc.
IMMUNOCORE HLDGS PLC / NOTE 2.500% 2/0 (45258DAB1)
IRHYTHM TECHNOLOGIES INC / NOTE 1.500% 9/0 (450056AB2)
KARYOPHARM THERAPEUTICS INC / NOTE 6.000% 5/1 (48576UAD8)
GUARDANT HEALTH INC / DEBT 1.250% 2/1 (40131MAD1)
REPLIGEN CORP / NOTE 1.000%12/1 (759916AD1)
ORKA / Oruka Therapeutics, Inc.
HNGE / Hinge Health, Inc.
KIDS / OrthoPediatrics Corp.
FULC / Fulcrum Therapeutics, Inc.
DNTH / Dianthus Therapeutics, Inc.
PEN / Penumbra, Inc.
SLNO / Soleno Therapeutics, Inc.
IRTC / iRhythm Holdings, Inc.
EXAS / Exact Sciences Corporation
NUVL / Nuvalent, Inc.
RPRX / Royalty Pharma plc
CDNA / CareDx, Inc.
DAWN / Day One Biopharmaceuticals, Inc.
ISRG / Intuitive Surgical, Inc.
SION / Sionna Therapeutics, Inc.
APGE / Apogee Therapeutics, Inc.
GKOS / Glaukos Corporation
XENE / Xenon Pharmaceuticals Inc.
US252131AK39 / CONV. NOTE
KRYS / Krystal Biotech, Inc.
CLDX / Celldex Therapeutics, Inc.
SYRE / Spyre Therapeutics, Inc.
HROW / Harrow, Inc.
HTFL / HeartFlow, Inc.
REPL / Replimune Group, Inc.
XNCR / Xencor, Inc.
LUNG / Pulmonx Corporation
DYN / Dyne Therapeutics, Inc.
BMRN / BioMarin Pharmaceutical Inc.
US64049MAB63 / NeoGenomics Inc
KYMR / Kymera Therapeutics, Inc.
US46333XAH17 / CONV. NOTE
INSP / Inspire Medical Systems, Inc.
SRPT / Sarepta Therapeutics, Inc.
EWTX / Edgewise Therapeutics, Inc.
ADPT / Adaptive Biotechnologies Corporation
CSTL / Castle Biosciences, Inc.
KNSA / Kiniksa Pharmaceuticals International, plc
AKRO / Akero Therapeutics, Inc.
ALGN / Align Technology, Inc.
GH / Guardant Health, Inc.
CBIO / Crescent Biopharma, Inc.
MDGL / Madrigal Pharmaceuticals, Inc.
APLS / Apellis Pharmaceuticals, Inc.
CELC / Celcuity Inc.
UNH / UnitedHealth Group Incorporated
RARE / Ultragenyx Pharmaceutical Inc.
ATEC / Alphatec Holdings, Inc.